How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,516 results for

Patch Delivered Medication

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Patch Delivered Medication

Patch Delivered Medication Patch Delivered Medication Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Patch Delivered Medication Patch (...) Delivered Medication Aka: Patch Delivered Medication , Transdermal Drug , Medication Patch From Related Chapters II. Precautions is heat sensitive Increases absorption and decreases duration Affected by fever, , heating pads, saunas Could dangerously increase levels (e.g. ) Avoid cutting patches unless specifically allowed es with evenly distributed medication may be cut (e.g. ) Avoid cutting patches with drug reservoir (e.g. , CQ) Avoid cutting patches for which exact dosing must be maintained (e.g

2018 FP Notebook

2. A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity

A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. A Study of the Use of Microneedle Patches to Deliver Topical Lidocaine in the Oral Cavity The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT03629041 Recruitment Status : Completed First Posted : August 14, 2018 Last Update Posted : September 20, 2018 Sponsor: Innoture Ltd

2018 Clinical Trials

3. A Transdermal Glucagon Patch for Severe Hypoglycemia

A Transdermal Glucagon Patch for Severe Hypoglycemia A Transdermal Glucagon Patch for Severe Hypoglycemia | CADTH.ca CADTH Document Viewer A Transdermal Glucagon Patch for Severe Hypoglycemia Table of Contents Search this document A Transdermal Glucagon Patch for Severe Hypoglycemia June 2017 Summary The ZP-Glucagon patch uses novel microneedle technology to deliver glucagon through the skin to people who are experiencing severe hypoglycemia (very low blood sugar). There is very limited (...) , delivers glucagon through the skin to ultimately be absorbed into the blood. Zosano Pharma's proprietary ZP-patch system (which can be used for delivery of various drugs), consists of a 3 cm 2 array of titanium microneedles in the centre of an adhesive patch contained within a retainer ring. 11,12 The microneedles are dry-coated with the drug or compound to be administered (in this case, glucagon). The retainer ring is attached to the bottom of the applicator, which in turn, is activated through spring

2017 CADTH - Issues in Emerging Health Technologies

4. A Transdermal Glucagon Patch for Severe Hypoglycemia

A Transdermal Glucagon Patch for Severe Hypoglycemia A Transdermal Glucagon Patch for Severe Hypoglycemia | CADTH.ca CADTH Document Viewer A Transdermal Glucagon Patch for Severe Hypoglycemia Table of Contents Search this document A Transdermal Glucagon Patch for Severe Hypoglycemia June 2017 Summary The ZP-Glucagon patch uses novel microneedle technology to deliver glucagon through the skin to people who are experiencing severe hypoglycemia (very low blood sugar). There is very limited (...) , delivers glucagon through the skin to ultimately be absorbed into the blood. Zosano Pharma's proprietary ZP-patch system (which can be used for delivery of various drugs), consists of a 3 cm 2 array of titanium microneedles in the centre of an adhesive patch contained within a retainer ring. 11,12 The microneedles are dry-coated with the drug or compound to be administered (in this case, glucagon). The retainer ring is attached to the bottom of the applicator, which in turn, is activated through spring

2017 CADTH - Issues in Emerging Health Technologies

5. Community pharmacies may be a useful place to deliver stop smoking services

any type of community-based pharmacy-delivered intervention aimed at stopping smoking, weight management or alcohol reduction compared to another type of intervention. For smoking, these could be “active” e.g. NRT patches, or “non-active” such as usual care. Usual care varied but was generally an intervention such as ad hoc advice or a thank you letter. It found 19 relevant studies (15 randomised controlled trials and four non-randomised studies) up to May 2014 with approximately 13,500 adult (...) without the need for a GP, and if successful, could become a countrywide operation to improve patient access to medication for minor problems. Lead GP for Furness with the Cumbria Clinical Commissioning Group, Dr Geoff Jolliffe said: “The idea of this scheme is for eligible patients to have access to a range of basic medicines and helpful advice from their local pharmacist”. What are the implications? This review provides evidence that community pharmacy-delivered interventions are effective

2019 NIHR Dissemination Centre

6. Community pharmacies may be a useful place to deliver stop smoking services

any type of community-based pharmacy-delivered intervention aimed at stopping smoking, weight management or alcohol reduction compared to another type of intervention. For smoking, these could be “active” e.g. NRT patches, or “non-active” such as usual care. Usual care varied but was generally an intervention such as ad hoc advice or a thank you letter. It found 19 relevant studies (15 randomised controlled trials and four non-randomised studies) up to May 2014 with approximately 13,500 adult (...) without the need for a GP, and if successful, could become a countrywide operation to improve patient access to medication for minor problems. Lead GP for Furness with the Cumbria Clinical Commissioning Group, Dr Geoff Jolliffe said: “The idea of this scheme is for eligible patients to have access to a range of basic medicines and helpful advice from their local pharmacist”. What are the implications? This review provides evidence that community pharmacy-delivered interventions are effective

2018 NIHR Dissemination Centre

7. Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

and systemic reactogenicity on the day of study product administration through 7 days after, and serious adverse events (SAEs) and new-onset chronic medical conditions through 180 days after study product administration. Secondary Outcome Measures : To evaluate the HAI titers following receipt of inactivated influenza vaccine delivered either by microneedle patch or by hypodermic needle (both vaccines administered by study staff). [ Time Frame: 28 days ] Immunogenicity testing will include performing (...) Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before

2015 Clinical Trials

8. Screening for atrial fibrillation with a wearable patch: Seek and ye shall find … and then what?

contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years. 6093 Posts Menu July 11, 2018 Screening for atrial fibrillation with a wearable patch: Seek and ye shall find … and then what? Posted By Categories , , , Tags , , , , Michael Joyce is a writer-producer with HealthNewsReview.org and tweets as A study published yesterday in the Journal of the American Medical Association (JAMA) raises important (...) Screening for atrial fibrillation with a wearable patch: Seek and ye shall find … and then what? Screening for atrial fibrillation with a wearable patch: Seek and ye shall find ... and then what? - HealthNewsReview.org Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published

2018 HealthNewsReview

9. Horizon scanning: what's next for medical and health research?

Horizon scanning: what's next for medical and health research? Horizon Scanning – research and innovation to transform the health of society by 2048 Findings from a survey and series of workshops held in 2017/18 The Academy of Medical Sciences 2 The Academy of Medical Sciences The Academy of Medical Sciences is the independent body in the UK representing the diversity of medical science. Our mission is to promote medical science and its translation into benefits for society. The Academy’s (...) elected Fellows are the United Kingdom’s leading medical scientists from hospitals, academia, industry and the public service. We work with them to promote excellence, influence policy to improve health and wealth, nurture the next generation of medical researchers, link academia, industry and the NHS, seize international opportunities and encourage dialogue about the medical sciences. Opinions expressed in this report do not necessarily represent the views of all participants at the event

2019 Academy of Medical Sciences

10. Patch Delivered Medication

Patch Delivered Medication Patch Delivered Medication Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Patch Delivered Medication Patch (...) Delivered Medication Aka: Patch Delivered Medication , Transdermal Drug , Medication Patch From Related Chapters II. Precautions is heat sensitive Increases absorption and decreases duration Affected by fever, , heating pads, saunas Could dangerously increase levels (e.g. ) Avoid cutting patches unless specifically allowed es with evenly distributed medication may be cut (e.g. ) Avoid cutting patches with drug reservoir (e.g. , CQ) Avoid cutting patches for which exact dosing must be maintained (e.g

2015 FP Notebook

11. Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch (PubMed)

-delivery system (syringe, pen, or pump). The patch is designed to deliver only boluses of fast-acting insulin (no basal insulin), mechanically controlled by the patient.Adults (n = 101) with T1D or T2D assessed their current mealtime insulin-delivery system and then assessed simulated (no active medication) patch use over a 3-day period. Participants evaluated mealtime insulin-delivery systems using eight measures from five domains (convenience, interference with daily activities, diabetes-related (...) Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch A basal-bolus insulin regimen is needed to achieve glycated hemoglobin A1c (HbA1c) below 7.0% in people with type 1 (T1D) or type 2 (T2D) diabetes who have significant loss of beta-cell function. Nonadherence to therapy is common and negatively affects the ability to reach treatment goals. We examined patient assessment of a new, wearable mealtime insulin-delivery system (patch) relative to their current mealtime insulin

Full Text available with Trip Pro

2018 Diabetes Therapy

12. Radiofrequency Ablation vs Sham Procedure for Symptomatic Cervical Inlet Patch

, cough and hoarseness. One particular symptom, called globus pharyngeus (the feeling of a ball in the back of the throat) is often associated with an inlet patch. There is no recognised treatment for symptomatic inlet patch. Anti-acid medications works for some but not all, which may in part be explained by the lack of acid producing cells in some inlet patches. Ablation of the inlet patch has been successful in small series using Argon Plasma Coagulation. This device is, however, associated (...) are safe and effective for reversal of inlet patch to normal mucosa, with improvement in symptoms. This study will use the BarrxTM system to treat patients with symptomatic inlet patch that is refractory to standard anti-acid medication, in a blinded sham controlled trial. Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 50 participants Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double (Participant

2018 Clinical Trials

13. When “healing” loses its meaning: A cynical medical resident meets Patch Adams

to KevinMD and never miss a story! Get free updates delivered free to your inbox. Subscribe Hire KevinMD to keynote your next event "Kevin's keynote presentation was perfect. Extremely rich in content, and a delivery that is world class." Related Posts More in Physician < Previous post Next post > Find jobs at Careers by KevinMD.com Search thousands of physician, PA, NP, and CRNA jobs now. × When “healing” loses its meaning: A cynical medical resident meets Patch Adams 7 comments Comments are moderated (...) When “healing” loses its meaning: A cynical medical resident meets Patch Adams How Patch Adams gave hope to a burnt out medical resident When “healing” loses its meaning: A cynical medical resident meets Patch Adams | | December 26, 2015 977 Shares The afternoon began like any other day in medical school. Students arrived at the lecture hall and took their seats. An individual with long blue-and-white hair and handlebar mustache entered the room wearing oversized fish-print pants, a loose

2015 KevinMD blog

14. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications

Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications Interventional Spine and Pain Procedures in Patients on Anti... : Regional Anesthesia and Pain Medicine You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page. Login No user account? Lippincott Journals Subscribers , use your username or email along with your password to log in. Remember me on this computer Register for a free account (...) procedures were published in 2015. Recent reviews evaluating bleeding complications in patients undergoing specific interventional pain procedures, the development of new regional anesthesia and acute pain guidelines, and the development of new anticoagulants and antiplatelet medications necessitate complementary updated guidelines. The authors desired coordination with the authors of the recently updated regional and acute pain anticoagulation guidelines. The latest evidence was sought through extensive

2018 American Society of Regional Anesthesia and Pain Medicine

15. Performance of the Monica Novii Wireless Patch System in Pre-term Labor

-term Labor Actual Study Start Date : April 20, 2017 Estimated Primary Completion Date : October 31, 2018 Estimated Study Completion Date : October 31, 2018 Groups and Cohorts Go to Group/Cohort Intervention/treatment Threatened PTL abdominal fetal/maternal monitoring Device: Abdominal fetal/maternal monitoring A single patch placed on the abdomen that incorporates 5 electrodes and a monitoring device Other Name: Novii Wireless Patch System Delivered PTL abdominal fetal/maternal monitoring Device (...) Performance of the Monica Novii Wireless Patch System in Pre-term Labor Performance of the Monica Novii Wireless Patch System in Pre-term Labor - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Performance

2017 Clinical Trials

16. Microneedle Patch Study in Healthy Infants/Young Children

of inactive ingredients in approved products. The total mass of excipients delivered by placebo microneedle patch will be <1.5 mg. The adhesive backing component is made from hypoallergenic material (commercial medical tapes designed to adhere to skin). Microneedle patches will be administered topically by manual application to the skin. The sites of microneedle patch application will be cleaned with an alcohol swab and allowed to dry before the microneedle patch is applied. The microneedle patches (...) Formulation 1. The total mass of excipients delivered by placebo microneedle patch will be <1.5 mg. The adhesive backing component is made from hypoallergenic material (commercial medical tapes designed to adhere to skin). Microneedle patches will be administered topically by manual application to the skin. The sites of microneedle patch application will be cleaned with an alcohol swab and allowed to dry before the microneedle patch is applied. The microneedle patches will be packaged and provided

2017 Clinical Trials

17. Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis

Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number (...) of saved studies (100). Please remove one or more studies before adding more. Evaluation of Efficacy, Duration of Remission and Safety of a Light and Occlusive Patch Therapy for Plaque Psoriasis The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details

2017 Clinical Trials

18. A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care. (PubMed)

A Randomized Controlled Trial of an Optimized Smoking Treatment Delivered in Primary Care. The effectiveness of smoking cessation treatment is limited in real-world use, perhaps because we have not selected the components of such treatments optimally nor have treatments typically been developed for and evaluated in real-world clinical settings.To validate an optimized smoking cessation treatment package that comprises intervention components identified as effective in factorial screening (...) experiments conducted as per the Multiphase Optimization Strategy (MOST).Adult smokers motivated to quit were recruited from primary care clinics (N = 623). Participants were randomized to receive either recommended usual care (R-UC; 10 min of in-person counseling, 8 weeks of nicotine patch, and referral to quitline services) or abstinence-optimized treatment (A-OT; 3 weeks of prequit mini-lozenges, 26 weeks of nicotine patch + mini-lozenges, three in-person and eight phone counseling sessions, and 7-11

Full Text available with Trip Pro

2018 Annals of behavioral medicine : a publication of the Society of Behavioral Medicine Controlled trial quality: uncertain

19. Chronic pain disorder medical treatment guideline.

-delivered collaborative care management intervention for primary care veteran patients produced clinically meaningful improvements in pain at 12-month follow-up compared with usual care by increasing non-opioid analgesic medications and without changing opioid usage for the management of chronic musculoskeletal pain. The management was directed by nurse case managers. Because the control group was usual care rather than an attention control, the non-specific effects of attention received (...) Chronic pain disorder medical treatment guideline. Chronic pain disorder medical treatment guideline. | National Guideline Clearinghouse success fail May JUN 09 2017 2018 2019 08 Jun 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed

2017 National Guideline Clearinghouse (partial archive)

20. Smartphone-delivered Automated Video-assisted Smoking Treatment for Patrons of a Food Resource Center

with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. Participants will be recruited from the Urban Mission, a non-profit food and resource center that serves approximately 20,000 people each year in the Oklahoma City metro area. Condition or disease Intervention/treatment Phase Smoking Cessation Behavioral: Self-help materials Drug: nicotine patch Other: Smartphone-delivered automated treatment Behavioral: Counseling Phase 4 Detailed Description: Smoking (...) materials. Drug: nicotine patch Participants who smoke >10 cigarettes per day will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg nicotine patches. Participants who smoke < 10 cigarettes per day will receive 6 weeks of 14 mg and 2 weeks of 7 mg nicotine patches. Other: Smartphone-delivered automated treatment Tailored video clips, text and graphical messages delivered automatically each week to the participant. Outcome Measures Go to Primary Outcome Measures : Smoking Status [ Time Frame

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>